Liminatus Pharma Inc. (LIMN)
Market Closed
16 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 11
-0.01
-5.2456%
After Hours
$
+0.01 +7.4692% 0. 12
3.69M Market Cap
- P/E Ratio
- Div Yield
1.58M Volume
- Eps
$ 0.12
Previous Close 
Want to track LIMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Liminatus Pharma Inc. (LIMN) Statistics
Valuation metrics
Market Cap 3.69M
Enterprise value 2.81M
Trailing P/E (ttm) -0.26
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) -21.86
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.03M
Average volume (90 days) 11.31M
Price summary
52-Week low 0.11
52-Week high 33.66
Beta -
50-Day moving average 0.19
200-Day moving average 0.48
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.94%
Return on equity 2.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.08
Total debt (mrq) -
Total Debt/Equity (mrq) -10.88
Current ratio (mrq) 0.96%
Book value per share (mrq) -0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
